Adverum to Present at the Cowen 39th Annual Health Care Conference
MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the company will be participating in the …